Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Melanoma 62Lymphoma, T-Cell, Cutaneous 42Lymphoma, Follicular 37Lymphoma, B-Cell, Marginal Zone 37Leukemia, Lymphocytic, Chronic, B-Cell 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Non-Hodgkin 36Lymphoma, Mantle-Cell 35Sezary Syndrome 34Mycosis Fungoides 34Lymphoma, Large B-Cell, Diffuse 34Hodgkin Disease 33Multiple Myeloma 32Lymphoma, Large-Cell, Immunoblastic 32Leukemia, Myeloid, Acute 32Burkitt Lymphoma 32Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Congenital Abnormalities 30Leukemia, Myeloid, Accelerated Phase 27Leukemia, Myeloid, Chronic-Phase 26Waldenstrom Macroglobulinemia 25Lymphoma, Large-Cell, Anaplastic 25Lymphoma 25Myeloproliferative Disorders 24Lymphoma, Extranodal NK-T-Cell 24Leukemia 23Immunoblastic Lymphadenopathy 23Leukemia, Myelomonocytic, Chronic 21Recurrence 20Myelodysplastic Syndromes 19

Interventions

pembrolizumab 3Nivolumab 3fludarabine 2atezolizumab 2Cyclophosphamide 2fludarabine phosphate 1epacadostat 1durvalumab 1avelumab 1aldesleukin 1Interleukin-2 1Docetaxel 1Carboxylesterase 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Microsatellite Instability × fludarabine phosphate × Dermatologic × Clear all
NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

University of Pittsburgh

Phase 2 Active not recruiting
20 enrolled
DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡